- TWD6.15bn
- TWD5.25bn
- TWD1.71bn
- 36
- 15
- 51
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,175 | 1,744 | 1,842 | 1,735 | 1,710 |
Cost of Revenue | |||||
Gross Profit | 724 | 651 | 719 | 699 | 697 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,165 | 1,689 | 1,840 | 1,714 | 1,731 |
Operating Profit | 9.79 | 55.5 | 2.14 | 20.7 | -21 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.6 | 92.9 | 281 | 65.9 | 30.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.9 | 62.1 | 196 | 56 | 14.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.01 | 58.1 | 196 | 55.1 | 12.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 4.01 | 58.1 | 196 | 55.1 | 12.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.014 | 0.178 | 0.574 | 0.126 | 0.04 |
Dividends per Share |